Next Member Meeting:

Date: Thursday, April 9, 2020.

Tentative Location: Firehouse Ministries (Birmingham)

11:00 Tour

12:00 Lunch & Speaker

01:00 Membership Meeting

Member Training Opportunities:

Thank you to those who attended our successful training on March 5th. More than 70 in attendance!

Registration link for Q2 training is coming soon. 

Previous sessions can be found on the AACRM Training page.

Alabama Senate Bill 174: Vote YES to regulate Tianeptine, an unapproved antidepressant that is poisoning people.

UPDATE: Due to Covid-19, there will probably not be any additional legislation passed this year.

UPDATE: Senate Bill 174 has been assigned to the Judicial Committee on 03-11-20 (Arthur Orr Sponsor)

UPDATE: House Bill 6 passed the House 102-1 on 03-10-20

UPDATE: House Bill 6 passed the Health Committee on 02-19-20

UPDATE: HB6 pre-filed after failing to be given a Senate vote during the 2019 session. (Sponsor Mike Holmes)

ACTION: Find out who your elected officials are HERE or HERE

- - -

Alabama has the opportunity to lead the nation again by addressing a substance that medical professionals, the CDC, treatment service providers and recovery organizations say is an unapproved antidepressant that's poisoning people, adding fuel to the fire that is the opioid public health crisis and is dangerously subverting treatment and recovery services.

Countries that have banned Tianna due to abuse potential:

  • Ukraine
  • Russia
  • Mexico
  • Georgia
  • Armenia
  • Michigan, United States

First prescribed as an opiate-like antidepressant in Europe as early as the 1950s, Tianeptine is commonly abused in the United States because it’s easily modified and easily accessible as an unregulated supplement. The drug is sold under various trade names, commonly known as Tianna, as a stress relief supplement, which can be purchased effortlessly online or in convenience retail environments in most states.

In recommended doses, Tianeptine does not make most users feel high and may address symptoms of depression differently than other antidepressants available. Serious problems arise, however, when the substance is taken in excess and modified to have stronger effects. It can be snorted, injected or even vaped., a widely-utilized online source for Tianeptine, includes a warning below the product which reads:

Tianeptine may have opiate-like withdrawal symptoms and shows potential for abuse. Ensure that usage is gradually reduced with care, and if ever in doubt, consult a qualified medical professional. If you have ever been addicted to opioids, Tianeptine may have an immediate addictive effect.” This product warning is more than substantiated by the increasingly mounting anecdotal evidence collected by treatment center admissions statistics and Tianeptine message boards addressing liver damage, withdrawal symptoms that can be painful, violent and even fatal.

Opiate addicts all over the country are realizing that Tianeptine is a cheap, federally legal loophole that will give them the fix they are looking for. The opiate-like effects of the drug are appealing to users. The CDC has reported exponentially increasing calls (+1620% 2012-2016) to poison control centers and recognizes deaths attributed to Tianeptine. 

Alyssa Wood’s testimony before Michigan’s Senate Judiciary Committee on how her addiction to Tianeptine sodium affected her while she was weaning herself off heroin. According to Wood, “Coming off heroin was easy compared to the withdrawals I experienced from Tianeptine. I could not get out of bed, go to work, have a normal, functioning day without it in my life.

With additional research, Tianeptine could have medical benefits later on. Because HB6 ranks the drug as Schedule II and not Schedule I, Alabama residents could legally use Tianeptine in the event that it is ever approved by the FDA. 

You can determine your elected officials by visiting Ask them to vote YES on House Bill 6.


“Not since the Alabama legislature scheduled Kratom as a controlled substance have we faced an unregulated substance as toxic as Tiannepine or one that poses as serious a threat to persons in treatment and recovery." 

- The Foundry Ministries


It allowed me as an individual struggling with a life-threatening opioid addiction to cheat on my sobriety. I self sabotaged my treatment by attempting to change without changing."

- Anonymous Person In Recovery


"I was able to deceive my employer, a transportation company, because I knew they could not test for Za Za (Tianna) and I could work while intoxicated. I had to address my dependence on Tianna after nodding out behind the wheel."

- Anonymous Person In Recovery


"Due to its widespread availability, the public perception is that it is safe. Substances like these are morale killers for our teams of dedicated professionals and literally a slippery slope for opioid addicts."

- Jacky Gann, World Exit Ministries


"Requires difficult judgement calls that impact people's lives due to our inability to test for Tianna."
- Tom Reynolds, His Way


What does the FDA say?

Alabama Senate Bill 111: Vote YES to prohibit the manufacture, marketing, sale, distribution, use, and possession of synthetic urine.

For more information, visit

"No person shall knowingly use his or her urine to defraud an alcohol, drug or urine test." SB111 sponsor is Senator Orr

U.S. House - H.R. 5172 & U.S. Senate S. 3067: Non-Opioid Choices Legislation

For more information, visit

  • The operating room is a key gateway to opioid misuse/addiction.
  • Every year, approximately 3 million patients prescribed opioids after surgery each year transitioned to persistent opioid use.
  • If we could get surgery patients non-opioid drugs instead of opioids to treat post-surgical pain, we could take one important step to reducing opioid abuse.
  • There is legislation currently in the U.S. House and U.S. Senate to help combat the opioid epidemic.
  • They are seeking additional U.S. Senators to co-sponsor S. 3067, the Non-Opioids Prevent Addiction In the Nation Act (NOPAIN Act), which would eliminate a Medicare policy that restricts access for doctors and patients to non-opioid pain relievers. Co-sponsors include: Sen. Doug Jones (D-AL), Sen. Joni Ernst (R-IA), Sen. Jeanne Shaheen (D-NH), and Sen. Joe Manchin (D-WV).
  • Similarly, in the U.S. House, we are seeking co-sponsors for H.R. 5172, the NOPAIN Act. Co-sponsors include: Rep.Terri Sewell (D-AL-7), David McKinley (R-WV-1), Rep. Alexander Mooney (R-WV-2), Rep. Anthony Brindisi (D-NY-22), Rep. John Moolenaar (R-MI-4), and Rep. Derek Kilmer (D-WA-6).